These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 18000656)
1. The effects of increased serotonergic activity on human sensory gating and its neural generators. Jensen KS; Oranje B; Wienberg M; Glenthøj BY Psychopharmacology (Berl); 2008 Mar; 196(4):631-41. PubMed ID: 18000656 [TBL] [Abstract][Full Text] [Related]
2. A single high dose of escitalopram disrupts sensory gating and habituation, but not sensorimotor gating in healthy volunteers. Oranje B; Wienberg M; Glenthoj BY Psychiatry Res; 2011 Apr; 186(2-3):431-6. PubMed ID: 20971512 [TBL] [Abstract][Full Text] [Related]
3. The effects of increased central serotonergic activity on prepulse inhibition and habituation of the human startle response. Jensen KS; Oranje B; Wienberg M; Glenthøj BY Neuropsychopharmacology; 2007 Oct; 32(10):2117-24. PubMed ID: 17299503 [TBL] [Abstract][Full Text] [Related]
4. Effects of ayahuasca on sensory and sensorimotor gating in humans as measured by P50 suppression and prepulse inhibition of the startle reflex, respectively. Riba J; Rodríguez-Fornells A; Barbanoj MJ Psychopharmacology (Berl); 2002 Dec; 165(1):18-28. PubMed ID: 12474114 [TBL] [Abstract][Full Text] [Related]
5. P50 suppression and its neural generators in antipsychotic-naive first-episode schizophrenia before and after 6 months of quetiapine treatment. Oranje B; Aggernaes B; Rasmussen H; Ebdrup BH; Glenthøj BY Schizophr Bull; 2013 Mar; 39(2):472-80. PubMed ID: 22241164 [TBL] [Abstract][Full Text] [Related]
6. Differential effects of acute serotonin and dopamine depletion on prepulse inhibition and p50 suppression measures of sensorimotor and sensory gating in humans. Mann C; Croft RJ; Scholes KE; Dunne A; O'Neill BV; Leung S; Copolov D; Phan KL; Nathan PJ Neuropsychopharmacology; 2008 Jun; 33(7):1653-66. PubMed ID: 17895917 [TBL] [Abstract][Full Text] [Related]
7. The effect of acute exogenous melatonin on P50 suppression in healthy male volunteers stratified for low and high gating levels. Ucar E; Lehtinen EK; Glenthøj BY; Oranje B J Psychopharmacol; 2012 Aug; 26(8):1113-8. PubMed ID: 22331175 [TBL] [Abstract][Full Text] [Related]
8. Increasing dopaminergic activity: effects of L-dopa and bromocriptine on human sensory gating. Oranje B; Gispen-de Wied CC; Westenberg HG; Kemner C; Verbaten MN; Kahn RS J Psychopharmacol; 2004 Sep; 18(3):388-94. PubMed ID: 15358983 [TBL] [Abstract][Full Text] [Related]
9. Is the loudness dependence of auditory evoked potentials modulated by the selective serotonin reuptake inhibitor citalopram in healthy subjects? Uhl I; Gorynia I; Gallinat J; Mulert C; Wutzler A; Heinz A; Juckel G Hum Psychopharmacol; 2006 Oct; 21(7):463-71. PubMed ID: 17029304 [TBL] [Abstract][Full Text] [Related]
10. Differential effects of nicotine on P50 amplitude, its gating, and their neural sources in low and high suppressors. Knott VJ; Fisher DJ; Millar AM Neuroscience; 2010 Oct; 170(3):816-26. PubMed ID: 20643194 [TBL] [Abstract][Full Text] [Related]
11. The effects of imipramine on P50 suppression, prepulse inhibition and habituation of the startle response in humans. Hammer TB; Oranje B; Glenthoj BY Int J Neuropsychopharmacol; 2007 Dec; 10(6):787-95. PubMed ID: 17250777 [TBL] [Abstract][Full Text] [Related]
12. Effects of nicotine on the amplitude and gating of the auditory P50 and its influence by dopamine D2 receptor gene polymorphism. Knott V; Millar A; Fisher D; Albert P Neuroscience; 2010 Mar; 166(1):145-56. PubMed ID: 19961902 [TBL] [Abstract][Full Text] [Related]
13. The effects of diazepam on sensory gating in healthy volunteers. van Luijtelaar G Neurosci Lett; 2003 Apr; 341(1):65-8. PubMed ID: 12676345 [TBL] [Abstract][Full Text] [Related]
14. An examination of acute changes in serotonergic neurotransmission using the loudness dependence measure of auditory cortex evoked activity: effects of citalopram, escitalopram and sertraline. Guille V; Croft RJ; O'Neill BV; Illic S; Phan KL; Nathan PJ Hum Psychopharmacol; 2008 Apr; 23(3):231-41. PubMed ID: 18196604 [TBL] [Abstract][Full Text] [Related]
15. Neuroleptic effects on P50 sensory gating in patients with first-episode never-medicated schizophrenia. Hong X; Chan RC; Zhuang X; Jiang T; Wan X; Wang J; Xiao B; Zhou H; Jiang L; Weng B Schizophr Res; 2009 Mar; 108(1-3):151-7. PubMed ID: 19106034 [TBL] [Abstract][Full Text] [Related]
16. Direct evidence that acutely enhancing serotonin with the selective serotonin reuptake inhibitor citalopram modulates the loudness dependence of the auditory evoked potential (LDAEP) marker of central serotonin function. Nathan PJ; Segrave R; Phan KL; O'Neill B; Croft RJ Hum Psychopharmacol; 2006 Jan; 21(1):47-52. PubMed ID: 16317803 [TBL] [Abstract][Full Text] [Related]
17. Sensory gating deficits assessed by the P50 event-related potential in subjects with schizotypal personality disorder. Cadenhead KS; Light GA; Geyer MA; Braff DL Am J Psychiatry; 2000 Jan; 157(1):55-9. PubMed ID: 10618013 [TBL] [Abstract][Full Text] [Related]
18. The adenosine antagonist theophylline impairs p50 auditory sensory gating in normal subjects. Ghisolfi ES; Prokopiuk AS; Becker J; Ehlers JA; Belmonte-de-Abreu P; Souza DO; Lara DR Neuropsychopharmacology; 2002 Oct; 27(4):629-37. PubMed ID: 12377399 [TBL] [Abstract][Full Text] [Related]
19. Haloperidol differentially modulates prepulse inhibition and p50 suppression in healthy humans stratified for low and high gating levels. Csomor PA; Stadler RR; Feldon J; Yee BK; Geyer MA; Vollenweider FX Neuropsychopharmacology; 2008 Feb; 33(3):497-512. PubMed ID: 17460616 [TBL] [Abstract][Full Text] [Related]
20. Divergent effects of increased serotonergic activity on psychophysiological parameters of human attention. Oranje B; Jensen K; Wienberg M; Glenthøj BY Int J Neuropsychopharmacol; 2008 Jun; 11(4):453-63. PubMed ID: 17971261 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]